中文
Tissue Regeneration Therapeutics (TRT) is a life science company that has discovered the world’s richest source of mesenchymal stem cells (MSCs), with potent regenerative, angiogenic, anti-inflammatory and immuno-regulatory properties. TRT calls them Human Umbilical Cord PeriVascular Cells (HUCPVCs).

TRT has also developed a biodegradable scaffold to be used in healing tissue defects. OsteoScaf™ is fully resorbable, osteoconductive, and is mechanically robust. OsteoScaf™ generates no inflammatory response, and has been granted 510(K) clearance by the FDA.

Together we build Very Powerful Biology.